Genprex
GNPX
38 hedge funds and large institutions have $35.4M invested in Genprex in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
36% more funds holding
Funds holding: 28 → 38 (+10)
23% more capital invested
Capital invested by funds: $28.7M → $35.4M (+$6.63M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
24% less call options, than puts
Call options by funds: $1.6M | Put options by funds: $2.09M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.93M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.54M |
| 3 |
Renaissance Technologies
New York
|
+$1.54M |
| 4 |
Millennium Management
New York
|
+$659K |
| 5 |
State Street
Boston,
Massachusetts
|
+$659K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$6.81M |
| 2 |
JP Morgan Chase
New York
|
-$439K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$439K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$439K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$220K |
GNPX Hedge Fund Activity: Q1 2021 in Review
38 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q1 2021, worth a combined $35.4M — up 23% from $28.7M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new GNPX positions and 4 closed out — a net gain of 10 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $5.93M. The largest seller was Altium Capital Management, cutting an estimated $6.81M.
- 38 institutional investors held Genprex (GNPX) as of Q1 2021, up from 28 in Q4 2020.
- Funds reported $35.4M of Genprex stock for Q1 2021, up 23% quarter-over-quarter.
- 14 funds opened new Genprex positions in Q1 2021 and 4 closed out, a net change of +10 holders.
- The largest Genprex buyer in Q1 2021 was Vanguard Group, an estimated $5.93M added.
- The largest Genprex seller in Q1 2021 was Altium Capital Management, an estimated $6.81M sold.
Based on aggregated 13F filings for Q1 2021.